Showing results (181-190 of 210) with videos related to
Sort By:
Pageof 21
BMC Public Health|May 24, 2019
One size does not fit all: HIV prevalence and correlates of risk for men who have sex with men, transgender women in multiple cities in Papua New GuineaAvi J Hakim, Kelsey Coy, Steven G Badman, et al.Tumour Virus Research|July 3, 2024
DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averagingMonica Molano, Dorothy A Machalek, Samuel Phillips, et al.Sexually Transmitted Infections|May 12, 2018
Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluationLouise M Causer, Rebecca J Guy, Sepehr N Tabrizi, et al.Sexually Transmitted Infections|June 23, 2026
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in AustraliaAnnie Tangey, Kirsty Smith, Belinda Hengel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening StudyAdam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.Geophysical Research Letters|June 16, 2015
Dynamic auroral storms on Saturn as observed by the Hubble Space TelescopeJ D Nichols, S V Badman, K H Baines, et al.Journal of Clinical Microbiology|April 15, 2016
Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical SpecimensP Toliman, S G Badman, J Gabuzzi, et al.Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.The Lancet Regional Health. Western Pacific|July 2, 2024
Clinical effectiveness and analytical quality of a national point-of-care testing network for sexually transmitted infections integrated into rural and remote primary care clinics in Australia, 2016-2022: an observational program evaluationLouise M Causer, James Ward, Kirsty Smith, et al.Papillomavirus Research (Amsterdam, Netherlands)|November 5, 2018
Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New GuineaPamela J Toliman, John M Kaldor, Steven G Badman, et al.Pageof 21